http://rdf.ncbi.nlm.nih.gov/pubchem/patent/TN-2014000077-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7c5e77c181522ee1fd44df1ae5ac2196
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-501
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D407-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D237-16
filingDate 2014-02-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2fe761beecf7f00b2187f17e850cb3cb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4b061879cf6ef1b848cd30f7b62ff75d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6ebe402ba6711a8f6dc8f66bda56ae7f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4c303f56e2287b77c363c49fab35f948
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bfe087e774db9ac921b2bddf650a70b8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_676df6298ba26094206e314fa78a384d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_51ea0324656c45be06cc9ebb7fb53c1b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8854a2a1459a9a801d89c8689ee4868c
publicationDate 2015-07-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber TN-2014000077-A1
titleOfInvention Pyridazinone compounds and their use as daao inhibitors
abstract The present invention provides compounds of formula (I) and pharmaceutically acceptable salts thereof, wherein R1 and R2 are as defined in the specification, processes for their preparation, pharmaceutical compositions containing them and their use in therapy.
priorityDate 2011-08-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID407318370
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID68153

Total number of triples: 26.